ARCUTIS BIOTHERAPEUTICS INC. - COMMON STOCK
13.24
31-1月-25 16:45:01
15 分の遅延
株式
-0.43
-3.15%
本日の幅
13.16 - 13.85
ISIN
N/A
ソース
NASDAQ
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 12 2023 22:00:49 提供 Nasdaq GlobeNewswire
-
29 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 11 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 11 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter 2023 Financial Results
25 10 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
20 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $100 Million Public Offering
19 10 2023 23:45:47 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
19 10 2023 16:04:44 提供 Nasdaq GlobeNewswire
-
06 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Appoints L. Todd Edwards as Chief Commercial Officer
27 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
25 9 2023 09:00:47 提供 Nasdaq GlobeNewswire
-
19 9 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 9 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
12 9 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
05 9 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Publishes Annual Environmental, Social, and Governance (ESG) Report
31 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Launches First Television Ad for ZORYVE® (Roflumilast) Cream 0.3%
29 8 2023 08:00:00 提供 Nasdaq GlobeNewswire